Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Galloway

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Expert Review of Clinical Immunology|March 7, 2022
JAK inhibitors: special issue forewordJames Galloway, Fabiola Atzeni
The Lancet Regional Health. Europe|September 11, 2025
Commentary on: diagnostic accuracy and predictive value of the QuantiFERON-TB Gold Plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyVictoria Allen, James Galloway
Rheumatology (Oxford, England)|January 7, 2021
COVID-19 and mortality in rare rheumatic diseases, a warning bell?James Galloway, Marwan Bukhari
The Lancet. Rheumatology|August 1, 2025
Optimising pneumococcal vaccine efficacy in rheumatoid arthritis: a strategic delay in methotrexate initiationKatie Bechman, James Galloway
Rheumatology (Oxford, England)|February 9, 2022
When should we start screening for hydroxychloroquine retinopathy?Edward Alveyn, James Galloway
Rheumatology (Oxford, England)|April 6, 2017
Twitter, #alternativefacts, careless whispers and RheumatologyMarwan Bukhari, James Galloway
The Lancet. Rheumatology|January 30, 2023
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic diseaseKatie Bechman, James Galloway
The Lancet. Rheumatology|June 14, 2025
Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritisFabiola Atzeni, James Galloway
The Lancet. Rheumatology|January 24, 2024
Improving COVID-19 vaccine response in individuals receiving methotrexateKatie Bechman, James Galloway
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 19, 2026
From inflammation to infection: Evaluating the association between TNF-alpha inhibition and risk of bloodstream infectionVictoria B Allen, James Galloway
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Expert Review of Clinical Immunology|March 7, 2022
JAK inhibitors: special issue forewordJames Galloway, Fabiola Atzeni
The Lancet Regional Health. Europe|September 11, 2025
Commentary on: diagnostic accuracy and predictive value of the QuantiFERON-TB Gold Plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyVictoria Allen, James Galloway
Rheumatology (Oxford, England)|January 7, 2021
COVID-19 and mortality in rare rheumatic diseases, a warning bell?James Galloway, Marwan Bukhari
The Lancet. Rheumatology|August 1, 2025
Optimising pneumococcal vaccine efficacy in rheumatoid arthritis: a strategic delay in methotrexate initiationKatie Bechman, James Galloway
Rheumatology (Oxford, England)|February 9, 2022
When should we start screening for hydroxychloroquine retinopathy?Edward Alveyn, James Galloway
Rheumatology (Oxford, England)|April 6, 2017
Twitter, #alternativefacts, careless whispers and RheumatologyMarwan Bukhari, James Galloway
The Lancet. Rheumatology|January 30, 2023
Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic diseaseKatie Bechman, James Galloway
The Lancet. Rheumatology|June 14, 2025
Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritisFabiola Atzeni, James Galloway
The Lancet. Rheumatology|January 24, 2024
Improving COVID-19 vaccine response in individuals receiving methotrexateKatie Bechman, James Galloway
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 19, 2026
From inflammation to infection: Evaluating the association between TNF-alpha inhibition and risk of bloodstream infectionVictoria B Allen, James Galloway
Pageof 21